European Injection Pen Market

European Injection Pen Market Size, Share & Trends Analysis Report by Type (Reusable and Disposable), by Disorder Type (Autoimmune Disorder, Hormonal Disorders, Orphan Disease, and Others), and Forecast 2020-2026
    Update Available - Forecast 2024-2030   

Published: Nov 2020 | Report Code: OMR2022770 | Category : Medical Devices | Delivery Format: /

The European injection pen market is projected to grow at a CAGR of 7.4% during the forecast period (2020-2026). The growth of the market in the region is attributed to the presence of the key players and a broad range of products offered by them. For instance, in November 2018, Novo Nordisk announced the launch of smart connected insulin pens NovoPen 6 and NovoPen Echo Plus. Besides, Sanofi SA also offers AllStar Pro pen injectors in markets across Europe. AllStar Pro is a new reusable pen injector available across Europe. Thus, easy availability of these injection pens, rising cases of several diseases including autoimmune disorders, hormonal disorders, and oncology are also among the primary aspects owing to which the growth of the Europe injection pen industry is graced up. 

Visit for Global Injection Pen Market Report at: https://www.omrglobal.com/industry-reports/injection-pen-market

The European injection pen market is segmented on the basis of type, and disorder type. Based on the type, the market is bifurcated into reusable and disposable. Most of the injectors available today are reusable as these require the replacement of only needles and cartridges. In addition, these can be used for a longer time, which makes them cost-effective. Based on the disorder type, the market is segmented into autoimmune disease, hormonal disorders, orphan disease, and others. The autoimmune disorder which includes diabetes and arthritis is a major application for an injection pen.

Geographically, the European injection pen market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK is anticipated to grow considerably over the forecast period. Further, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, AstraZeneca Plc, Bayer AG, Novo Nordisk A/S, and Sanofi SA among others are some of the prominent players operating in the European injection pen market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market. 

Research Methodology

The market study of the Europe injection pen market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for medical device manufacturers, injection pen manufacturers, pharmaceutical companies, research institutes and universities, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  1. Europe Injection Pen Market Research and Analysis by Type
  2. Europe Injection Pen Market Research and Analysis by Disorder Type

The Report covers:

  • Comprehensive research methodology of the Europe injection pen market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Europe Injection pen market.
  • Insights about market determinants which are stimulating the Europe injection pen market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players. 

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Market Determinants

3.1. Motivators

3.2. Restraints

3.3. Opportunities

4. Market Segmentation

4.1. Europe Injection Pen Market by Type

4.1.1. Reusable 

4.1.2. Disposable 

4.2. Europe Injection Pen Market by Disorder Type

4.2.1. Autoimmune Disorders

4.2.2. Hormonal Disorders

4.2.3. Orphan Diseases

4.2.4. Others

5. Regional Analysis

5.1.1. UK

5.1.2. Germany

5.1.3. France

5.1.4. Italy

5.1.5. Spain

5.1.6. Rest of Europe 

6. Company Profiles 

6.1. AstraZeneca Plc

6.1.1. Overview

6.1.2. AstraZeneca Plc in Europe

6.1.3. AstraZeneca Plc in Injection Pen Landscape

6.1.4. Recent Developments

6.2. Bayer AG

6.3. Biocorp Production SA

6.4. Eli Lilly and Co.

6.5. F. Hoffmann-La Roche Ltd.

6.6. Gerresheimer AG

6.7. GlaxoSmithKline Plc

6.8. Haselmeier GmbH

6.9. Merck KGaA

6.10. Mylan N.V.

6.11. Novartis International AG

6.12. Novo Nordisk A/S

6.13. Owen Mumford Ltd.

6.14. Sanofi SA

6.15. Ypsomed Holding AG


1. EUROPE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)

2. EUROPE REUSABLE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

3. EUROPE DISPOSABLE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

4. EUROPE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY DISORDER TYPE, 2019-2026 ($ MILLION)

5. EUROPE INJECTION PEN FOR AUTOIMMUNE DISORDERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

6. EUROPE INJECTION PEN FOR HORMONAL DISORDERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

7. EUROPE INJECTION PEN FOR ORPHAN DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

8. EUROPE INJECTION PEN FOR OTHER DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

9. EUROPE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)


1. EUROPE INJECTION PEN MARKET SHARE BY TYPE, 2019 VS 2026 (%)

2. EUROPE INJECTION PEN MARKET SHARE BY DISORDER TYPE, 2019 VS 2026 (%)

3. EUROPE INJECTION PEN MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)

4. UK INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)

5. GERMANY INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)

6. FRANCE INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)

7. ITALY INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)

8. SPAIN INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)

9. REST OF EUROPE INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)